ArticleJournal of oncology research and therapy2023

High Dose Cyclophosphamide for the Treatment of Severe Immune Checkpoint Inhibitor Related Adverse Events.

Timothy Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.